Whether something works “better” than Lexapro depends entirely on what Lexapro isn’t doing well for you. Lexapro (escitalopram) is one of the most widely prescribed antidepressants, and for many people it works fine. But if you’re dealing with sexual side effects, weight gain, persistent brain fog, or just not feeling better, there are real alternatives worth discussing with your prescriber. The best replacement isn’t a single drug; it’s the one that targets whatever problem Lexapro is causing for you.
If Sexual Side Effects Are the Problem
This is the most common reason people want off Lexapro. SSRIs as a class are notorious for dampening libido, making it harder to orgasm, or causing erectile difficulties. In clinical comparisons, about 45% of people taking escitalopram reported sexual dysfunction, compared to roughly 7.5% of those on bupropion (Wellbutrin). Ejaculation problems showed a similar gap: 32% on escitalopram versus 10% on bupropion.
Bupropion works through a completely different mechanism than Lexapro. Instead of raising serotonin levels, it acts on dopamine and norepinephrine, which is why it largely spares sexual function. It’s effective for depression, though it’s not a first-line choice for anxiety. If your main diagnosis is generalized anxiety disorder, switching to bupropion alone could leave your anxiety undertreated. Some prescribers add bupropion alongside a lower dose of Lexapro to counterbalance the sexual side effects while preserving the anxiety relief.
If Weight Gain Is a Concern
Lexapro causes modest but measurable weight gain: about 1.4 pounds at six months and 3.6 pounds by two years, according to data reviewed by Harvard Health. That may sound small, but for some people the trajectory keeps climbing, and the psychological toll of unexplained weight gain compounds the depression it’s supposed to treat.
Bupropion stands out here, too. It was the only antidepressant associated with slight weight loss (about a quarter pound) at six months. That advantage fades somewhat by two years, when bupropion users gained an average of 1.2 pounds, but that’s still well below most other options. If weight is your primary frustration, bupropion is the most evidence-backed alternative. Newer antidepressants like vortioxetine (Trintellix) also tend to be more weight-neutral, though head-to-head data on long-term weight is limited.
If Lexapro Isn’t Working Well Enough
Sometimes the issue isn’t side effects but inadequate relief. Your mood is slightly better, maybe, but you’re still not functioning the way you want to. In that situation, switching medications is one option, but augmentation (adding a second medication to Lexapro) is often tried first.
The most common add-on medications fall into a few categories. Low-dose atypical antipsychotics like aripiprazole (Abilify) or brexpiprazole (Rexulti) are frequently prescribed alongside SSRIs for treatment-resistant depression. Bupropion is another popular addition, since it works on different brain chemistry and can boost energy and motivation that Lexapro alone may not address. Lithium, though often associated with bipolar disorder, has decades of evidence supporting its use as an antidepressant booster. Your prescriber will typically start any augmentation agent at a low dose and increase gradually.
For people who haven’t responded to multiple medication trials, esketamine (Spravato), a nasal spray derived from ketamine, is an option. It’s administered in a clinical setting and requires monitoring afterward, but it can produce noticeable improvement within days rather than the weeks most antidepressants require.
If Anxiety Is Your Main Issue
Lexapro is actually one of the better SSRIs for generalized anxiety disorder, so if it’s falling short on anxiety control specifically, the next step is often a different drug class rather than a different SSRI. SNRIs like venlafaxine (Effexor) work on both serotonin and norepinephrine, giving them broader neurochemical coverage.
In a head-to-head trial of 74 patients with generalized anxiety disorder, venlafaxine produced a higher response rate (86%) than escitalopram (79%) after eight weeks, and a similar remission rate (67% versus 61%). Interestingly, escitalopram kicked in faster, with greater anxiety reduction during the first four weeks. By eight weeks, venlafaxine had caught up and pulled slightly ahead. Side effect profiles were comparable between the two. So if Lexapro helps your anxiety somewhat but not enough, venlafaxine may offer a meaningful step up, though the difference is modest.
If Brain Fog or Cognitive Dullness Is the Issue
Some people on Lexapro describe feeling emotionally blunted, mentally slow, or like they’re thinking through cotton. This is a recognized effect of SSRIs, and it’s distinct from depression itself. Vortioxetine (Trintellix) is a newer antidepressant that has received attention specifically for its effects on cognitive function, including processing speed, memory, and the ability to concentrate.
In a randomized, double-blind study comparing vortioxetine to escitalopram in people whose depression hadn’t fully responded to prior treatment, both drugs improved cognitive performance over eight weeks. The differences weren’t statistically significant in that trial, but the numerical trends favored vortioxetine across multiple measures of thinking speed and everyday functioning. Other studies have been more definitive about vortioxetine’s cognitive benefits, which is why it’s often positioned as the go-to option when mental sharpness is a priority. The tradeoff: it can cause nausea, especially early on, and it’s more expensive than generic Lexapro.
Therapy as an Alternative or Complement
If your search is motivated by wanting to get off medication entirely, cognitive behavioral therapy (CBT) deserves serious consideration. Multiple international clinical guidelines recommend CBT as a first-line treatment for depression, and cumulative evidence has demonstrated that psychotherapy outperforms medication for long-term outcomes. The key advantage is relapse prevention: people who achieve remission through CBT have a significantly lower risk of their depression returning compared to those who achieve remission through antidepressants alone.
That said, CBT requires consistent effort, access to a trained therapist, and time. It works best for mild to moderate depression. For severe depression, the combination of medication plus therapy consistently outperforms either one alone. Internet-based CBT programs have made access easier and produce similar results to in-person therapy for many people.
Genetic Testing to Guide Your Switch
Pharmacogenomic testing analyzes how your genes affect your ability to metabolize certain medications. The idea is straightforward: if your body breaks down Lexapro too quickly (making it less effective) or too slowly (amplifying side effects), a genetic test can flag that and point toward drugs your body handles better.
The evidence is promising but uneven. A meta-analysis in Frontiers in Psychiatry found that patients who received prescriptions guided by genetic testing were 41% to 78% more likely to achieve remission compared to those prescribed medications the usual way. Results varied depending on which test was used. GeneSight-guided prescribing, the most widely available option, showed significantly improved response and remission rates in subgroup analyses. Other tests had mixed results.
Genetic testing won’t hand you a single perfect drug, but it can narrow the field and reduce the trial-and-error process. It’s most useful if you’ve already tried two or more medications without success.
What Switching Actually Looks Like
If you and your prescriber decide to try a different SSRI or SNRI, the process is usually simpler than people expect. Switching from Lexapro to most other SSRIs or SNRIs can often be done as a direct switch: you stop Lexapro one day and start the new medication the next. This is possible because these drugs occupy similar receptor sites, so there’s overlap in their effects during the transition.
Switching to a completely different class, like bupropion, may involve a brief cross-taper where you gradually lower Lexapro while introducing the new drug. Your prescriber will account for Lexapro’s half-life, which is long enough that it lingers in your system for a few days after your last dose, providing a natural buffer. Most people notice some transition symptoms (mild dizziness, irritability, or sleep changes) for a week or two, but serious discontinuation effects are uncommon when the switch is managed properly.